JPMorgan Chase & Co. Has Lowered Expectations for U.S. Physical Therapy (NYSE:USPH) Stock Price

U.S. Physical Therapy (NYSE:USPH) had its price objective lowered by stock analysts at JPMorgan Chase & Co. from $120.00 to $110.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target would suggest a potential upside of 47.44% from the company’s current price.

Several other equities analysts have also weighed in on the stock. Bank of America upgraded shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and upped their price objective for the company from $100.00 to $115.00 in a report on Monday, December 16th. Barrington Research lowered their target price on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating on the stock in a report on Friday, February 28th. JMP Securities began coverage on shares of U.S. Physical Therapy in a report on Monday, December 16th. They issued an “outperform” rating and a $113.00 target price on the stock. Citizens Jmp upgraded shares of U.S. Physical Therapy to a “strong-buy” rating in a report on Monday, December 16th. Finally, StockNews.com lowered shares of U.S. Physical Therapy from a “hold” rating to a “sell” rating in a research note on Friday, February 28th. One analyst has rated the stock with a sell rating, one has issued a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, U.S. Physical Therapy currently has a consensus rating of “Moderate Buy” and a consensus target price of $109.00.

U.S. Physical Therapy Stock Performance

Shares of USPH opened at $74.61 on Wednesday. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. The stock has a market capitalization of $1.13 billion, a P/E ratio of 79.37, a price-to-earnings-growth ratio of 3.54 and a beta of 1.51. The firm’s fifty day simple moving average is $85.14 and its two-hundred day simple moving average is $87.08. U.S. Physical Therapy has a 12 month low of $74.46 and a 12 month high of $113.63.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing analysts’ consensus estimates of $0.69 by ($0.04). U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The firm had revenue of $180.45 million for the quarter, compared to the consensus estimate of $173.10 million. As a group, analysts predict that U.S. Physical Therapy will post 2.67 EPS for the current year.

Insider Buying and Selling at U.S. Physical Therapy

In other news, COO Graham D. Reeve sold 1,730 shares of the stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $82.11, for a total transaction of $142,050.30. Following the completion of the transaction, the chief operating officer now directly owns 7,168 shares of the company’s stock, valued at $588,564.48. This represents a 19.44 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 1.70% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. CBIZ Investment Advisory Services LLC grew its position in shares of U.S. Physical Therapy by 59.8% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company’s stock valued at $29,000 after acquiring an additional 122 shares during the period. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of U.S. Physical Therapy during the 4th quarter valued at approximately $39,000. Venturi Wealth Management LLC grew its position in shares of U.S. Physical Therapy by 3,200.0% during the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the company’s stock valued at $64,000 after acquiring an additional 704 shares during the period. KBC Group NV grew its position in shares of U.S. Physical Therapy by 68.6% during the 3rd quarter. KBC Group NV now owns 774 shares of the company’s stock valued at $66,000 after acquiring an additional 315 shares during the period. Finally, Lazard Asset Management LLC bought a new position in shares of U.S. Physical Therapy during the 4th quarter valued at approximately $84,000.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.